Resistance and susceptibility of mice to bacterial infection. IV. Genetic and cellular basis of resistance to chronic infection with Brucella abortus.

PubWeight™: 1.34‹?› | Rank: Top 10%

🔗 View Article (PMID 6809847)

Published in J Infect Dis on September 01, 1982

Authors

M Ho, C Cheers

Articles citing this

Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect Immun (1986) 2.83

Effects of cytokines on intracellular growth of Brucella abortus. Infect Immun (1993) 2.33

Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev (2003) 2.03

Demonstration of acquired resistance in Bcgr inbred mouse strains infected with a low dose of BCG montreal. Clin Exp Immunol (1984) 1.82

Interleukin-10 downregulates protective immunity to Brucella abortus. Infect Immun (1995) 1.68

Ability of mononuclear phagocytes from cattle naturally resistant or susceptible to brucellosis to control in vitro intracellular survival of Brucella abortus. Infect Immun (1990) 1.28

What have we learned from brucellosis in the mouse model? Vet Res (2012) 1.13

Lack of a role for natural killer cells in early control of Brucella abortus 2308 infections in mice. Infect Immun (1995) 1.02

Macrophage plasma membrane cholesterol contributes to Brucella abortus infection of mice. Infect Immun (2002) 0.99

Genetic resistance to Brucella abortus in the water buffalo (Bubalus bubalis). Infect Immun (2006) 0.97

Nramp1 is not a major determinant in the control of Brucella melitensis infection in mice. Infect Immun (2003) 0.88

Growth of Brucella abortus in macrophages from resistant and susceptible mouse strains. Clin Exp Immunol (2000) 0.85

Kinetics of placental colonization of mice inoculated intravenously with Brucella abortus at day 15 of pregnancy. Br J Exp Pathol (1983) 0.85

NRAMP1 3' untranslated region polymorphisms are not associated with natural resistance to Brucella abortus in cattle. Infect Immun (2007) 0.84

Alteration of protective and serologic responses in BALB/c mice vaccinated with chemically modified versus nonmodified proteins of Brucella abortus 19. Infect Immun (1994) 0.83

Articles by these authors

(truncated to the top 100)

Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet (2003) 6.23

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood (1994) 4.13

Activated macrophages in congenitally athymic "nude mice" and in lethally irradiate mice. J Immunol (1975) 3.96

A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut (2002) 3.73

Regulation of cellular interferon production: enhancement by antimetabolites. Proc Natl Acad Sci U S A (1970) 3.66

Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation (1983) 3.60

Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55

Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med (1992) 3.30

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect Immun (1978) 3.24

The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med (1975) 3.09

Fungal infections in liver transplant recipients. Transplantation (1985) 3.07

Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03

Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis (1991) 2.87

Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis (1988) 2.76

Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant or susceptible mice. Infect Immun (1978) 2.65

A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1990) 2.50

The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis (1999) 2.49

Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother (2001) 2.41

The pathophysiology of malaria. Adv Parasitol (1992) 2.33

Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect Immun (1993) 2.24

Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis (1986) 2.18

Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect Immun (1995) 2.05

Efficacy of cutting balloon angioplasty for lesions at the ostium of the coronary arteries. J Invasive Cardiol (1999) 2.04

Viral infections in renal transplant recipients. Infect Immun (1976) 2.03

Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. Ann Emerg Med (1998) 2.02

Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol (1983) 2.00

Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. JAMA (1990) 2.00

The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med (1997) 1.98

In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection. Cell Immunol (1982) 1.97

Resistance and susceptibility of mice to bacterial infection: histopathology of listeriosis in resistant and susceptible strains. Infect Immun (1980) 1.97

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford) (2005) 1.91

Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. Lancet (1991) 1.89

Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis (1985) 1.88

Difficult thoracic lesions: CT-guided biopsy experience in 150 cases. Radiology (1988) 1.87

Restriction in adoptive transfer of resistance to Listeria monocytogenes. II. Use of congenic and mutant mice show transfer to be H-2K restricted. Cell Immunol (1983) 1.86

Malaria in splenectomized patients: report of four cases and review. Clin Infect Dis (1993) 1.85

Macrophage behaviour during the complaisant phase of murine pertussis. Immunology (1969) 1.85

Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol (1999) 1.77

Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs. CMAJ (2001) 1.75

A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy. J Infect Dis (2000) 1.71

Virus infections after transplantation in man. Brief review. Arch Virol (1977) 1.70

Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect Immun (1995) 1.70

No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acquir Immune Defic Syndr (1990) 1.67

Reactivation of murine cytomegalovirus by cyclophosphamide. Nature (1977) 1.67

Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis (1990) 1.67

Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N Engl J Med (1979) 1.61

Interferon. Annu Rev Microbiol (1975) 1.61

Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice. Blood (1998) 1.58

Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol (1991) 1.57

Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. J Virol (1989) 1.55

Cytokine production in the murine response to brucella infection or immunization with antigenic extracts. Immunology (1993) 1.54

V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. Urology (2001) 1.54

Macrophage activation during experimental murine brucellosis: a basis for chronic infection. Infect Immun (1979) 1.54

Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow. Blood (2000) 1.54

Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G(q)alpha-coupled phospholipase C-beta1. J Biol Chem (1997) 1.53

Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol (1988) 1.50

Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus. Infect Immun (1980) 1.50

Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA (1987) 1.49

The steady state in cellular immunity. II. Immunological complaisance in murine pertussis. Aust J Exp Biol Med Sci (1967) 1.49

Serum vitamin D metabolites in very low birth weight infants with and without rickets and fractures. J Pediatr (1989) 1.47

Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay. J Clin Microbiol (1992) 1.46

Efficacy of cutting balloon angioplasty for in-stent restenosis: an intravascular ultrasound evaluation. J Invasive Cardiol (2001) 1.46

McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol (2001) 1.45

Hepatitis C virus. Another agent transmitted by transplanted organs. N Engl J Med (1991) 1.45

Cytokine response of T-cell subsets from Brucella abortus-infected mice to soluble Brucella proteins. Infect Immun (1993) 1.44

Cellular origin of interferon induced by bacterial lipopolysaccharide. Infect Immun (1977) 1.44

Colony-forming cells and colony-stimulating activity during listeriosis in genetically resistant or susceptible mice. Cell Immunol (1986) 1.43

Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun (1996) 1.43

Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis (1985) 1.43

Efficacy of directional coronary atherectomy before stent implantation for coronary ostial lesions. J Invasive Cardiol (2000) 1.42

Antibodies against haemorrhagic fever viruses in Kenya populations. Trans R Soc Trop Med Hyg (1983) 1.41

Recombinant interleukin-6 protects mice against experimental bacterial infection. Infect Immun (1992) 1.41

Accentuation of production of human interferon by metabolic inhibitors. Proc Soc Exp Biol Med (1972) 1.41

Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction. Science (1975) 1.40

Dynamic alteration in splenic function during acute falciparum malaria. N Engl J Med (1987) 1.40

Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions. J Immunol (1997) 1.39

Tolerance to the induction of interferons by endotoxin and virus: role of a humoral factor. Proc Soc Exp Biol Med (1965) 1.38

Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother (2001) 1.38

A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects. J Infect Dis (1978) 1.37

The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO J (1996) 1.34

Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon. Infect Immun (1995) 1.34

Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. Br J Haematol (1987) 1.34

Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis (1991) 1.33

Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts. Infect Immun (1995) 1.33

Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid (1998) 1.33

Reactivation of herpes simplex virus after decompression of the trigeminal nerve root. J Infect Dis (1978) 1.32

Pathogenesis and cellular immunity in experimental murine brucellosis. Dev Biol Stand (1984) 1.32

The effect of group education on improving attitudes about AIDS risk reduction. N Y State J Med (1987) 1.32

Diversity of SHV and TEM beta-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26. Antimicrob Agents Chemother (2001) 1.31

Polyadenylic acid-polyuridylic acid (poly A : U) and experimental murine brucellosis. II. Macrophages as target cells of poly A : U in experimental brucellosis. Immunology (1978) 1.30

Cooperation between carrier-reactive and hapten-sensitive cells in vitro. Nat New Biol (1971) 1.30

Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. J Infect Dis (1984) 1.29

A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. J Infect Dis (1983) 1.28

Cytomegalovirus infection in patients receiving immunosuppressive therapy for rheumatologic disorders. J Infect Dis (1976) 1.28

Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies: a prospective study. Cancer (1981) 1.27

The steady state in cellular immunity. I. Chemotherapy and superinfection in murine tuberculosis. Aust J Exp Biol Med Sci (1967) 1.27